enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Editas Medicine - Wikipedia

   en.wikipedia.org/wiki/Editas_Medicine

   Editas Medicine was originally founded with the name "Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, [7] and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures; the name was changed to the current "Editas Medicine" two ...

3. Editas Medicine Stock History: The Story Behind the ... - AOL

   www.aol.com/news/editas-medicine-stock-history...

   Here's the story behind the biotech stock that could be the best way to profit from the discovery of the century: CRISPR-Cas9 gene editing.

4. Investors one-year losses grow to 78% as the stock ... - AOL

   www.aol.com/news/investors-one-losses-grow-78...

   Editas Medicine, Inc. ( NASDAQ:EDIT ) shareholders should be happy to see the share price up 27% in the last quarter...

5. Editas Medicine (EDIT) Gains As Market Dips: What You ... - AOL

   www.aol.com/news/editas-medicine-edit-gains...

   Editas Medicine (EDIT) closed at $76.14 in the latest trading session, marking a +0.29% move from the prior day.

6. Editas Medicine Announces Third Quarter 2024 Results and ...

   lite.aol.com/tech/story/0022/20241104/9266630.htm

   About Editas Medicine As a clinical-stage gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and ...

7. Editas Medicine (EDIT) Reports Q3 Loss, Misses Revenue ... - AOL

   www.aol.com/news/editas-medicine-edit-reports-q3...

   Editas (EDIT) delivered earnings and revenue surprises of 6.90% and 99.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

8. What You Need To Know About Editas Medicine, Inc.'s ... - AOL

   www.aol.com/news/know-editas-medicine-inc-nasdaq...

   A look at the shareholders of Editas Medicine, Inc. (NASDAQ:EDIT) can tell us which group is most powerful. Generally... What You Need To Know About Editas Medicine, Inc.'s (NASDAQ:EDIT) Investor ...

9. Editas Medicine (EDIT) Outpaces Stock Market Gains ... - AOL

   www.aol.com/news/editas-medicine-edit-outpaces...

   In the latest trading session, Editas Medicine (EDIT) closed at $63.18, marking a +1.64% move from the previous day. Editas Medicine (EDIT) Outpaces Stock Market Gains: What You Should Know Skip ...